shock – an overview.ppt

Upload: hareen-reddy

Post on 20-Feb-2018

220 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    1/19

    SHOCK AN OVERVIEWSHOCK AN OVERVIEW

    Definition a multifaceted syndromeleading to systemic & localized tissue

    hypoperfusion, resulting in cellular

    hypoxia & multiple organ dysfunction

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    2/19

    DESCRIPTION

    1. Perfusion may be decreased with obvioussigns such as hypotension

    . Perfusion may be decreased due to

    maldistribution as in septic shoc! wheresystemic perfusion may appear elevated

    ". #igns of malperfusion may be subtle & lead tosignificant organ damage

    $. Prognosis determined by degree of shoc!,duration, %o of organs affected, previousorgan dysfunction & 'enetic predisposition

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    3/19

    ETIOLOGICAL CLASSIFICATION

    ( )ypovolemic *oss of circ intravascular vol & decrease in cardiac

    preload +ay be hge trauma, '- bleed, nontraumatic internal

    bleed aneurysm, ectopic rupture/ or bleeding P0 %onhgeic fluid loss from '- tract vomiting,diarrhea,

    fistula/, urinary losses D+/, evaporative fever,hyperthermia/ & internal fluid shifts"rdspace loss asin intestinal obstruction/

    linical signs depend on volume lost & rapidity of loss +ost common form2ll forms have a component of decreased preload

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    4/19

    ontd

    ( 3bstructive

    +echanical obstruction to normal cardiac

    output causing decrease in systemic

    perfusion

    ardiac tamponade, tension pneumothorax.linical signs raised 40P, muffled heart

    sounds & decreased breath sounds

    massive pulmonary embolism & air embolism

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    5/19

    contd

    ( ardiogenic

    aused by myocardial pump/ failure

    5xtensive myocardial infarction most commoncause

    6educed contractility cardiomyopathy, sepsis

    induced/, 2#, +#, atrial myxoma,

    dysrhythmias

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    6/19

    contd

    ( Distributive

    aused by systemic vasodilatation infection,

    anaphylaxis/ resulting in systemic hypotension &

    inc 7 dec 3

    #-6# most common cause of distributive shoc! +ost common cause of #-6# is epsis

    Despite the high 3 there is cellular hypoxia

    due to disruption of mitochondrial function2naphylaxis, severe liver dysfunction, neurgenic

    shoc! spinal trauma/ also cause distributive

    shoc!

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    7/19

    contd

    ( 5ndocrine shoc!

    )ypothyroidism, hyperthyroidism with cardiac

    collapse, adrenal insufficiency

    2drenal insufficiency may be a contributor to

    shoc! in critically ill patients. ase

    unresponsive to treatment should be tested

    for adrenal insufficiency.

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    8/19

    PATHOPHYSIOLOGY

    ( 6esult of shoc! decreased tissue perfusion &cellular hypoxia

    ( ell hypoxiacellular ischemia, alteration in a,

    c2+P & formation of 386

    ( )ypoxia enhanced vasc permiability & dec

    control on memb tpt fns

    ( 6eperfusion release of 386 cell

    damage

    ( %eutrophil activation & release of

    proinflammatory cyto!ines

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    9/19

    contd

    ( 8urther cell damage, third spacing,activation of coag, microcirc thrombosis,

    collapse & further ischemia

    ( -n sepsis & #-6# initial event isinflammatory response

    ( +icrocirculatory collapse leads to +38

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    10/19

    DIAGNOSIS

    ( 0ital signs )6, 9P, temp, urine output,

    #p3 traditional measures

    ( :;

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    11/19

    contd

    ( >rine output end organ response to shoc!,

    1 hrs needed to measure( #p3 early indicator of hypoxia, may be

    invalid in hypothermic pt

    ( -nvasive hemodynamic monitoring better 29P, 0P, P2,#v3, 3esophageal

    doppler, 8lowtrac, lidco, picco

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    12/19

    RESUSCITATION END POINTS

    ( *actic acid production

    ells with inade?uate 3 will switch to

    anaerobic metabolism

    lactic acid byproduct of anaerobic met elevation of lactate is measure of severity of

    shoc!. *actate also elevated in liver & !idney

    failure, 26D#

    6ate of clearance of lactate a better mar!er

    for ade?uate resuscitation

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    13/19

    contd

    ( 9ase deficit

    9ase deficit is amt of base re?uired to titratewhole blood to a normal p)

    5levated base deficit correlates with severityof shoc!

    correction of 95 is a guide to further mgnt

    ( -ntra mucosal p) monitoring +esentric hypodynamic response to shoc!

    'astric tonometry measures intramucosal p)& is an early indicator of gut hypoperfusion,correlates with mortality

    @echnically difficult less used

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    14/19

    TREATMENT

    6apid recognition & restoration of perfusionis !ey to preventing multi organ failure &

    death. -n all forms of shoc! rapid

    restoration of preload with fluids is the 1st

    treatment

    @reat shoc! while identifying its cause

    8urther treatment depends on etiology

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    15/19

    contd

    ( )ypovol shoc!

    6apid infusion of large vol of fluids thru largebore -0 cannulae, central access may be

    needed incl P2/

    -f cause be, then after initial " ltrs of fluids,

    blood is transfused

    6ecent data supports use of pac!ed cells A

    88P A platelets in a 1B1B1 ratio

    8actor 0--a may also be useful 6esuscitation complete only when base excess

    & lactate corrected to acceptable levels

    0asoconstrictors rarely needed

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    16/19

    contd

    ( 3bstructive shoc!

    -dentify cause & relieve early

    Pericardiocentesis, pericardiectomy for

    tamponade

    %eedle decompression , tube thoracostomy

    for tension pneumothorax

    0entilatory, cardiac support, thrombolytics &

    heparin for P5

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    17/19

    contd

    ( ardiogenic shoc!

    3ptimise preload with infusion of fluids

    3ptimize contractility with inotropes, balancing

    cardiac 3 demand

    2dCust afterload to maximise 3. pts may

    need vasodilation to decrease #06

    Diuresis may be indicated >nderlying cardiac cause needs treatment

    P2 is recommended to guide therapy

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    18/19

    contd

    ( Distributive shoc!

    -n #-6# & sepsis , shoc! due to toxins7mediator

    induced vasodilatation

    2ggressive fluid resuscitation

    Pressors after infusion of volume Dobutamine, noradr, vasopressin

    *ow dose steroids if evidence of adrenal

    insufficiency @reat underlying cause of #-6#

  • 7/24/2019 SHOCK AN OVERVIEW.ppt

    19/19